KR20030075718A - 유전자 발현효율이 높으며 간세포 성장인자의 두 가지이형체를 동시에 발현하는 하이브리드 간세포 성장인자유전자 - Google Patents
유전자 발현효율이 높으며 간세포 성장인자의 두 가지이형체를 동시에 발현하는 하이브리드 간세포 성장인자유전자 Download PDFInfo
- Publication number
- KR20030075718A KR20030075718A KR1020020015074A KR20020015074A KR20030075718A KR 20030075718 A KR20030075718 A KR 20030075718A KR 1020020015074 A KR1020020015074 A KR 1020020015074A KR 20020015074 A KR20020015074 A KR 20020015074A KR 20030075718 A KR20030075718 A KR 20030075718A
- Authority
- KR
- South Korea
- Prior art keywords
- hgf
- gene
- pck
- pcp
- hybrid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/4753—Hepatocyte growth factor; Scatter factor; Tumor cytotoxic factor II
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Abstract
Description
5' 프라이머 | 3' 프라이머 | 증폭산물 |
gHGF3(서열번호: 3) | gHGF4(서열번호: 4) | HGF 유전자 절편 2(HGF-F2) |
gHGF3(서열번호: 3) | gHGF10(서열번호: 5) | HGF 유전자 절편 3(HGF-F3) |
gHGF5(서열번호: 6) | gHGF7(서열번호: 7) | HGF 유전자 절편 5(HGF-F5) |
gHGF12(서열번호: 8) | gHGF7(서열번호: 7) | HGF 유전자 절편 7(HGF-F7) |
gHGF13(서열번호: 9) | gHGF7(서열번호: 7) | HGF 유전자 절편 8(HGF-F8) |
gHGF6(서열번호: 10) | gHGF7(서열번호: 7) | HGF 유전자 절편 6(HGF-F6) |
5' 프라이머 | 3' 프라이머 | 증폭산물 |
gHGF1(서열번호: 11) | gHGF2(서열번호: 12) | HGF 유전자 절편 1(HGF-F1) |
gHGF8(서열번호: 13) | gHGF9(서열번호: 14) | HGF 유전자 절편 4(HGF-F4) |
cHGF5(서열번호: 15) | cHGF3(서열번호: 16) | HGF 유전자 cDNA(cHGF)dHGF 유전자 cDNA(dHGF) |
Claims (9)
- 인간 간세포 성장인자(Hepatocyte Growth Factor; HGF) cDNA의 엑손(exon) 4와 엑손 5 사이에 고유의 또는 이종의 인트론(intron) 서열이 삽입된, 유전자 발현효율이 높으며 HGF 및 dHGF(deleted varient of HGF)의 두 가지 이형체를 동시에 발현하는 하이브리드(hybrid) HGF 유전자.
- 제 1 항에 있어서,서열번호: 2의 염기서열을 갖는 하이브리드 HGF 유전자.
- 제 1 항에 있어서,서열번호: 19 내지 서열번호: 21의 염기서열 중 어느 하나의 염기서열을 갖는 하이브리드 HGF 유전자.
- 제 1 항 내지 제 3 항 중 어느 한 항의 유전자를 포함하는 벡터.
- 제 4 항에 있어서,pCK-HGF-X2, pCK-HGF-X3, pCK-HGF-X6,pCK-HGF-X7,pCK-HGF-X8, pCP-HGF-X2, pCP-HGF-X3, pCP-HGF-X6, pCP-HGF-X7 또는 pCP-HGF-X8인 벡터.
- 제 4 항 또는 제 5 항의 벡터에 의해 형질전환된 미생물.
- 제 6 항에 있어서,대장균 Top10F' pCK-HGFX7(기탁번호: KCCM-10361) 또는 대장균 Top10F' pCP-HGFX7(기탁번호: KCCM-10362)인 미생물.
- 제 1 항 내지 제 3 항 중 어느 한 항의 하이브리드 HGF 유전자를 포함하는 허혈성 질환 또는 간질환 치료 및 예방용 약학 조성물.
- 제 8 항에 있어서,제 4 항의 벡터를 포함하는 조성물.
Priority Applications (18)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020020015074A KR100562824B1 (ko) | 2002-03-20 | 2002-03-20 | 유전자 발현효율이 높으며 간세포 성장인자의 두 가지이형체를 동시에 발현하는 하이브리드 간세포 성장인자유전자 |
PT03744561T PT1490492E (pt) | 2002-03-20 | 2003-03-20 | Gene do factor de crescimento de hepatócitos híbrido com eficiência de expressão elevada de dois heterotipos do factor de crescimento de hepatócitos |
EP03744561A EP1490492B1 (en) | 2002-03-20 | 2003-03-20 | Hybrid hepatocyte growth factor gene having high expression efficiency of two heterotypes of hepatocyte growth factor |
ES03744561T ES2298538T3 (es) | 2002-03-20 | 2003-03-20 | Gen del factor de crecimiento hepatocitario hibrido que tiene una eficacia de expresion elevada de dos heterotipos del factor de crecimiento hepatocitario. |
PCT/KR2003/000548 WO2003078568A2 (en) | 2002-03-20 | 2003-03-20 | Hybrid hepatocyte growth factor gene having high expression efficiency of two heterotypes of hepatocyte growth factor |
CNB038065347A CN100378219C (zh) | 2002-03-20 | 2003-03-20 | 高效表达两种不同类型肝细胞生长因子的杂合肝细胞生长因子基因 |
DK03744561T DK1490492T3 (da) | 2002-03-20 | 2003-03-20 | Hybridt hepatocytvækstfaktorgen med höj ekspressionseffektivitet af to heterotyper af hepatocytvækstfaktor |
BRPI0303570A BRPI0303570B8 (pt) | 2002-03-20 | 2003-03-20 | "construção de hgf, microrganismo transgênico, vetor e composição farmacêutico" |
AT03744561T ATE380826T1 (de) | 2002-03-20 | 2003-03-20 | Hybrid-hepatozyten-wachstumsfaktorgen mit hoher expressionseffizienz von zwei hepatozyten- wachstumsfaktor-heterotypen |
DE60318026T DE60318026T2 (de) | 2002-03-20 | 2003-03-20 | Hybrid-hepatozyten-wachstumsfaktorgen mit hoher expressionseffizienz von zwei hepatozyten-wachstumsfaktor-heterotypen |
AU2003210053A AU2003210053A1 (en) | 2002-03-20 | 2003-03-20 | Hybrid hepatocyte growth factor gene having high expression efficiency of two heterotypes of hepatocyte growth factor |
JP2003576563A JP4057537B2 (ja) | 2002-03-20 | 2003-03-20 | 遺伝子発現効率が高く、肝細胞成長因子の2つの異型体を同時に発現するハイブリッド肝細胞成長因子遺伝子 |
US10/944,277 US7812146B2 (en) | 2002-03-20 | 2004-09-20 | Hybrid hepatocyte growth factor gene having high expression efficiency of two heterotypes of hepatocyte growth factor |
HK06100717A HK1080895A1 (en) | 2002-03-20 | 2006-01-17 | Hybrid hepatocyte growth factor gene having high expression efficiency of two heterotypes of hepatocyte growth factor |
US11/957,170 US7838505B2 (en) | 2002-03-20 | 2007-12-14 | Hybrid hepatocyte growth factor gene having high expression efficiency of two heterotypes of hepatocyte growth factor |
US12/650,860 US7745174B2 (en) | 2002-03-20 | 2009-12-31 | Hybrid hepatocyte growth factor gene having high expression efficiency of two heterotypes of hepatocyte growth factor |
US12/908,765 US8338385B2 (en) | 2002-03-20 | 2010-10-20 | Hybrid hepatocyte growth factor gene having high expression efficiency of two heterotypes of hepatocyte growth factor |
US15/642,307 USRE48404E1 (en) | 2002-03-20 | 2017-07-05 | Hybrid hepatocyte growth factor gene having high expression efficiency of two heterotypes of hepatocyte growth factor |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020020015074A KR100562824B1 (ko) | 2002-03-20 | 2002-03-20 | 유전자 발현효율이 높으며 간세포 성장인자의 두 가지이형체를 동시에 발현하는 하이브리드 간세포 성장인자유전자 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20030075718A true KR20030075718A (ko) | 2003-09-26 |
KR100562824B1 KR100562824B1 (ko) | 2006-03-23 |
Family
ID=28036130
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020020015074A KR100562824B1 (ko) | 2002-03-20 | 2002-03-20 | 유전자 발현효율이 높으며 간세포 성장인자의 두 가지이형체를 동시에 발현하는 하이브리드 간세포 성장인자유전자 |
Country Status (14)
Country | Link |
---|---|
US (5) | US7812146B2 (ko) |
EP (1) | EP1490492B1 (ko) |
JP (1) | JP4057537B2 (ko) |
KR (1) | KR100562824B1 (ko) |
CN (1) | CN100378219C (ko) |
AT (1) | ATE380826T1 (ko) |
AU (1) | AU2003210053A1 (ko) |
BR (1) | BRPI0303570B8 (ko) |
DE (1) | DE60318026T2 (ko) |
DK (1) | DK1490492T3 (ko) |
ES (1) | ES2298538T3 (ko) |
HK (1) | HK1080895A1 (ko) |
PT (1) | PT1490492E (ko) |
WO (1) | WO2003078568A2 (ko) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101325674B1 (ko) * | 2008-01-25 | 2013-11-06 | 주식회사 바이로메드 | 간세포 성장인자의 둘 이상의 이형체들을 이용한 심장 질환의 치료 및 예방 |
USRE48404E1 (en) | 2002-03-20 | 2021-01-26 | Helixmith Co., Ltd | Hybrid hepatocyte growth factor gene having high expression efficiency of two heterotypes of hepatocyte growth factor |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2628928A1 (en) * | 2005-11-10 | 2007-05-24 | Receptor Biologix, Inc. | Hepatocyte growth factor intron fusion proteins |
AU2009234598C1 (en) * | 2008-04-09 | 2012-08-23 | Viromed Co., Ltd. | Lyophilized DNA formulations for enhanced expression of plasmid DNA |
EP2216399A1 (en) * | 2009-01-30 | 2010-08-11 | Université de la Méditerranée | Human soluble CD146, preparation and uses thereof |
CN102120047A (zh) * | 2010-01-11 | 2011-07-13 | 上海优益绩国际贸易有限公司 | 血运重建基因药物靶向投递缓释支架 |
JP6240337B2 (ja) | 2013-10-22 | 2017-11-29 | バイロメッド カンパニー リミテッド | 肝細胞増殖因子の2つ以上のアイソフォームを利用した筋萎縮性側索硬化症の予防又は治療用組成物 |
CN107073078B (zh) * | 2014-09-26 | 2021-07-06 | 赫利世弥斯株式会社 | 利用肝细胞生长因子和基质细胞衍生因子1α的用于预防或治疗外周动脉疾病的组合物 |
WO2017135795A1 (ko) * | 2016-02-04 | 2017-08-10 | 주식회사 에스엘바이젠 | 간세포성장인자를 발현하는 중간엽줄기세포 및 이의 용도 |
EP3733855A4 (en) * | 2017-12-29 | 2021-03-03 | Helixmith Co., Ltd | ADENO-ASSOCIATED VIRUS (AAV) VECTOR INCLUDING A HYBRID HGF GENE INTRODUCED INTO ITS BREAST |
KR102245539B1 (ko) | 2018-02-12 | 2021-04-29 | 주식회사 지앤피바이오사이언스 | 코어-쉘 구조의 마이크로 입자를 유효성분으로 포함하는 성장인자 유전자 발현 증가용 조성물 |
CN108611367B (zh) * | 2018-04-24 | 2019-11-19 | 北京诺思兰德生物技术股份有限公司 | 一类通过质粒载体介导的基因治疗重组载体 |
US20190381138A1 (en) * | 2018-05-17 | 2019-12-19 | Helixmith Co., Ltd. | Treatment of neuropathic pain associated with chemotherapy-induced peripheral neuropathy |
EP3823981A4 (en) * | 2018-07-17 | 2022-04-06 | Neuromyon Inc. | TREATMENT OF NEUROPATHY WITH DNA CONSTRUCTS EXPRESSING IGF-1 ISOFORMS |
EP3823677A4 (en) | 2018-07-19 | 2022-06-01 | Helixmith Co., Ltd. | FREEZE-DRIED PHARMACEUTICAL COMPOSITIONS INTENDED FOR NAKED-DNA GENE THERAPY |
CN110747214B (zh) * | 2019-03-13 | 2021-12-31 | 深圳市臻质医疗科技有限公司 | DNA片段、具有长效表达和细胞特异性结合能力的mRNA-抗体融合分子及其制备方法 |
KR20210035126A (ko) | 2021-03-18 | 2021-03-31 | 주식회사 지앤피바이오사이언스 | 코어-쉘 구조의 마이크로 입자를 유효성분으로 포함하는 성장인자 유전자 발현 증가용 조성물 |
WO2022211454A1 (ko) * | 2021-03-29 | 2022-10-06 | 주식회사 헬릭스미스 | 샤르코-마리-투스병 예방 또는 치료용 약제학적 조성물 |
US20230212603A1 (en) * | 2021-10-06 | 2023-07-06 | G&P Bioscience Co., Ltd. | Development of optimized recombinant expression construct |
Family Cites Families (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ232813A (en) * | 1989-03-10 | 1992-08-26 | Snow Brand Milk Products Co Ltd | Human fibroblast glycoprotein, cell differentiation, blood vessel endothelial cell growth factor, cellular immunology inforcing factor of 78 or 74 thousand daltons plus or minus two thousand daltons |
US5703055A (en) * | 1989-03-21 | 1997-12-30 | Wisconsin Alumni Research Foundation | Generation of antibodies through lipid mediated DNA delivery |
US6673776B1 (en) * | 1989-03-21 | 2004-01-06 | Vical Incorporated | Expression of exogenous polynucleotide sequences in a vertebrate, mammal, fish, bird or human |
US5693622A (en) * | 1989-03-21 | 1997-12-02 | Vical Incorporated | Expression of exogenous polynucleotide sequences cardiac muscle of a mammal |
CA2022752C (en) * | 1989-08-11 | 1998-07-07 | Naomi Kitamura | Hepatic parenchymal cell growth factor, gene encoding the same, process for producing the factor, and transformants producing the factor |
US6706694B1 (en) * | 1990-03-21 | 2004-03-16 | Vical Incorporated | Expression of exogenous polynucleotide sequences in a vertebrate |
DK0539590T3 (da) * | 1990-07-13 | 1999-10-11 | Snow Brand Milk Products Co Ltd | Plasmid indeholdende DNA, som koder for aminosyresekvensen af TCF-II, en transformeret celle og fremstilling af et fysiolog |
US5661133B1 (en) * | 1991-11-12 | 1999-06-01 | Univ Michigan | Collateral blood vessel formation in cardiac muscle by injecting a dna sequence encoding an angiogenic protein |
US6498144B1 (en) * | 1993-10-18 | 2002-12-24 | North Shore - Long Island Jewish Research Institute | Use of scatter factor to enhance angiogenesis |
US5837676A (en) * | 1993-10-18 | 1998-11-17 | Long Island Jewish Medical Center | Use of scatter factor to enhance angiogenesis |
US5652225A (en) * | 1994-10-04 | 1997-07-29 | St. Elizabeth's Medical Center Of Boston, Inc. | Methods and products for nucleic acid delivery |
US20030148968A1 (en) * | 1995-02-28 | 2003-08-07 | Hammond H. Kirk | Techniques and compositions for treating cardiovascular disease by in vivo gene delivery |
DE69634567T2 (de) * | 1995-08-29 | 2006-02-16 | Anges Mg Inc., Toyonaka | Ein medikament,das hgf gen enthält |
US5830879A (en) * | 1995-10-02 | 1998-11-03 | St. Elizabeth's Medical Center Of Boston, Inc. | Treatment of vascular injury using vascular endothelial growth factor |
US6121246A (en) * | 1995-10-20 | 2000-09-19 | St. Elizabeth's Medical Center Of Boston, Inc. | Method for treating ischemic tissue |
JP2002515065A (ja) | 1997-05-06 | 2002-05-21 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | 脈管形成トランスジーンのインビボ送達により心不全および心室再構成を処置するための技術および組成物 |
JPH11246433A (ja) | 1998-03-03 | 1999-09-14 | Sumitomo Pharmaceut Co Ltd | 心筋梗塞治療剤 |
AU766238B2 (en) | 1998-03-09 | 2003-10-09 | Caritas St. Elizabeth's Medical Center Of Boston, Inc. | Compositions and methods for modulating vascularization |
US20040228834A1 (en) * | 1998-03-09 | 2004-11-18 | Jeffrey Isner | Compositions and methods for modulating vascularization |
AU5065599A (en) * | 1998-08-05 | 2000-02-28 | Sumitomo Pharmaceuticals Company, Limited | Preparations for the administration of hepatocyte growth factor |
CN1182874C (zh) * | 1999-10-29 | 2005-01-05 | 安增子摩祺株式会社 | 糖尿病性局部缺血疾病的基因治疗制剂 |
EP1225921A1 (en) | 1999-11-05 | 2002-07-31 | The Regents of the University of California | TECHNIQUES AND COMPOSITIONS FOR TREATING CARDIOVASCULAR DISEASE BY i IN VIVO /i GENE DELIVERY |
CN1142272C (zh) * | 2000-02-02 | 2004-03-17 | 中国人民解放军军事医学科学院百环生物医学研究中心 | 携带人肝细胞生长因子基因的重组腺病毒的用途 |
DE60134021D1 (de) * | 2000-06-27 | 2008-06-26 | Anges Mg Inc | Pharmazeutische zubereitungen zur angiogenese-therapie |
US20020172663A1 (en) * | 2001-01-23 | 2002-11-21 | Maria Palasis | Localized myocardial injection method for treating ischemic myocardium |
KR100562824B1 (ko) * | 2002-03-20 | 2006-03-23 | 주식회사 바이로메드 | 유전자 발현효율이 높으며 간세포 성장인자의 두 가지이형체를 동시에 발현하는 하이브리드 간세포 성장인자유전자 |
WO2006121532A2 (en) * | 2005-03-31 | 2006-11-16 | Mytogen, Inc. | Treatment for heart disease |
US20090202606A1 (en) * | 2008-01-25 | 2009-08-13 | Viromed Co., Ltd. | Treatment and Prevention of Cardiac Conditions Using Two or More Isoforms of Hepatocyte Growth Factor |
AU2009234598C1 (en) * | 2008-04-09 | 2012-08-23 | Viromed Co., Ltd. | Lyophilized DNA formulations for enhanced expression of plasmid DNA |
-
2002
- 2002-03-20 KR KR1020020015074A patent/KR100562824B1/ko active IP Right Grant
-
2003
- 2003-03-20 EP EP03744561A patent/EP1490492B1/en not_active Expired - Lifetime
- 2003-03-20 AU AU2003210053A patent/AU2003210053A1/en not_active Abandoned
- 2003-03-20 DE DE60318026T patent/DE60318026T2/de not_active Expired - Lifetime
- 2003-03-20 AT AT03744561T patent/ATE380826T1/de active
- 2003-03-20 BR BRPI0303570A patent/BRPI0303570B8/pt not_active IP Right Cessation
- 2003-03-20 ES ES03744561T patent/ES2298538T3/es not_active Expired - Lifetime
- 2003-03-20 CN CNB038065347A patent/CN100378219C/zh not_active Expired - Lifetime
- 2003-03-20 WO PCT/KR2003/000548 patent/WO2003078568A2/en active IP Right Grant
- 2003-03-20 DK DK03744561T patent/DK1490492T3/da active
- 2003-03-20 JP JP2003576563A patent/JP4057537B2/ja not_active Expired - Lifetime
- 2003-03-20 PT PT03744561T patent/PT1490492E/pt unknown
-
2004
- 2004-09-20 US US10/944,277 patent/US7812146B2/en active Active
-
2006
- 2006-01-17 HK HK06100717A patent/HK1080895A1/xx not_active IP Right Cessation
-
2007
- 2007-12-14 US US11/957,170 patent/US7838505B2/en not_active Expired - Lifetime
-
2009
- 2009-12-31 US US12/650,860 patent/US7745174B2/en not_active Ceased
-
2010
- 2010-10-20 US US12/908,765 patent/US8338385B2/en not_active Expired - Lifetime
-
2017
- 2017-07-05 US US15/642,307 patent/USRE48404E1/en not_active Expired - Lifetime
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
USRE48404E1 (en) | 2002-03-20 | 2021-01-26 | Helixmith Co., Ltd | Hybrid hepatocyte growth factor gene having high expression efficiency of two heterotypes of hepatocyte growth factor |
KR101325674B1 (ko) * | 2008-01-25 | 2013-11-06 | 주식회사 바이로메드 | 간세포 성장인자의 둘 이상의 이형체들을 이용한 심장 질환의 치료 및 예방 |
Also Published As
Publication number | Publication date |
---|---|
US7745174B2 (en) | 2010-06-29 |
JP2005520512A (ja) | 2005-07-14 |
US20120010273A1 (en) | 2012-01-12 |
USRE48404E1 (en) | 2021-01-26 |
US20050079581A1 (en) | 2005-04-14 |
DE60318026T2 (de) | 2008-11-20 |
CN100378219C (zh) | 2008-04-02 |
AU2003210053A8 (en) | 2003-09-29 |
US20100105878A1 (en) | 2010-04-29 |
US7812146B2 (en) | 2010-10-12 |
HK1080895A1 (en) | 2006-05-04 |
CN1643149A (zh) | 2005-07-20 |
JP4057537B2 (ja) | 2008-03-05 |
DK1490492T3 (da) | 2008-03-17 |
WO2003078568A2 (en) | 2003-09-25 |
AU2003210053A1 (en) | 2003-09-29 |
DE60318026D1 (de) | 2008-01-24 |
US7838505B2 (en) | 2010-11-23 |
US8338385B2 (en) | 2012-12-25 |
EP1490492A4 (en) | 2006-05-31 |
KR100562824B1 (ko) | 2006-03-23 |
EP1490492A2 (en) | 2004-12-29 |
US20090131350A1 (en) | 2009-05-21 |
EP1490492B1 (en) | 2007-12-12 |
WO2003078568A3 (en) | 2003-11-27 |
BRPI0303570B8 (pt) | 2021-05-25 |
PT1490492E (pt) | 2008-03-25 |
ES2298538T3 (es) | 2008-05-16 |
BRPI0303570B1 (pt) | 2018-04-24 |
ATE380826T1 (de) | 2007-12-15 |
BR0303570A (pt) | 2005-07-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
USRE48404E1 (en) | Hybrid hepatocyte growth factor gene having high expression efficiency of two heterotypes of hepatocyte growth factor | |
JP3802292B2 (ja) | 上皮細胞に特異的な成長因子をコードするdna | |
Tashiro et al. | Deduced primary structure of rat hepatocyte growth factor and expression of the mRNA in rat tissues. | |
JPH10502527A (ja) | TGF−βファミリーの新規な成長/分化因子 | |
JPH09118695A (ja) | 組換え繊維芽細胞成長因子 | |
EP2576625B1 (en) | Fusion protein having factor vii activity | |
JPH0763378B2 (ja) | TGF−βをコードしているDNA | |
JP2001501442A (ja) | 調節遺伝子およびその使用 | |
JPH06502538A (ja) | 上皮細胞成長因子(egf)との相同性をもつヘパリン結合性マイトジェン | |
JP3121611B2 (ja) | 神経成長因子を真核生物細胞において発現させるための遺伝子ベクター | |
JP2002511762A (ja) | ネズミおよびヒトのサーベラス様蛋白およびそれらを含有する組成物 | |
JP4031499B2 (ja) | 同一のn末端を有する塩基性繊維芽細胞増殖因子の高レベル発現 | |
WO1994009812A1 (en) | METHOD FOR PRODUCING LARGE LATENT TRANSFORMING GROWTH FACTOR-β COMPLEXES AND LARGE LATENCY ASSOCIATED PEPTIDE | |
JPH0761266B2 (ja) | 変異ヒトプロウロキナ−ゼ | |
KR20010052887A (ko) | 안지오스타틴-결합 단백질 | |
JPH093099A (ja) | マクロファージ刺激蛋白質改変体およびその製造法 | |
WO1999040193A1 (en) | Angiopoietin homolog zapo3, dna encoding it, and method of making it | |
TWI419901B (zh) | 利用腦衰蛋白反應媒介蛋白-1(crmp-1)及其片段治療癌症之組合物及方法 | |
JPH03505276A (ja) | 再配列された組織プラスミノーゲン活性化因子及びその産生方法 | |
JPS61192288A (ja) | ヒトエラスタ−ゼ2の生物工学的製造 | |
KR20000065110A (ko) | 성숙형뼈유도인자의제조방법 | |
EP1723236A1 (en) | Method for the recombinant expression of an n-terminal fragment of hepatocyte growth factor | |
KR20030003840A (ko) | 항 혈관신생 단백질, 이 단백질을 코딩하는 유전자 및이를 포함하는 약학적 조성물 | |
KR20000071891A (ko) | Vegf 의존성 질병 치료용 vegf 융합단백질과 그 발현벡터 | |
Mertvetsov | Chemo-enzymatic synthesis of the human angiogenin gene. Construction of bacterial strains, producers of human angiogenin. Elaboration of a technology for the purification and preparation of angiogenin |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20121206 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20131120 Year of fee payment: 9 |
|
FPAY | Annual fee payment |
Payment date: 20141127 Year of fee payment: 10 |
|
FPAY | Annual fee payment |
Payment date: 20151218 Year of fee payment: 11 |
|
FPAY | Annual fee payment |
Payment date: 20161227 Year of fee payment: 12 |
|
FPAY | Annual fee payment |
Payment date: 20171222 Year of fee payment: 13 |
|
FPAY | Annual fee payment |
Payment date: 20200102 Year of fee payment: 15 |